Kliovance Side Effects: Complete Safety Guide
When Do Side Effects Start? How Long Do They Last? Timeline, Contraindications & Food Interactions
Table of Contents
- Key Takeaways
- Common Side Effects of Kliovance: What to Expect
- When Do Kliovance Side Effects Start?
- How Long Do Kliovance Side Effects Last?
- Kliovance Side Effects Timeline: A Week‑by‑Week Guide
- Contraindications: Who Should Not Take Kliovance
- Food Interactions with Kliovance: What You Need to Know
- Serious Side Effects & When to Seek Medical Help
- Kliovance Side Effects FAQs
Key Takeaways: Kliovance Side Effects
- Most common: Breast tenderness, spotting/breakthrough bleeding, headache, nausea – affect >1 in 10 women initially.
- Onset: Side effects usually appear within the first 1‑3 months of starting treatment.
- Duration: Most transient side effects resolve within 2‑3 months as your body adjusts. Spotting typically settles after 3‑6 months.
- Serious risks: Blood clots, breast cancer, endometrial cancer, stroke – rare but require vigilance. See section 2 of the PIL for detailed risk.
- Contraindications: Do not take if you have or had breast cancer, unexplained bleeding, blood clots, liver disease, or are pregnant/breastfeeding.
- Food interactions: No major food restrictions; avoid grapefruit juice (theoretical interaction).
Kliovance is an effective continuous combined HRT, but like all medicines, it can cause side effects. Understanding when they typically start, how long they last, and what to do about them helps you manage treatment confidently and safely.
Stop Kliovance and Seek Immediate Help If:
You develop signs of a blood clot (painful swollen leg, sudden chest pain, difficulty breathing), jaundice (yellow skin/eyes), sudden severe headache or migraine, swollen face/tongue (angioedema), or if you become pregnant. Also seek urgent advice if you experience heavy or persistent irregular bleeding after the first 6 months.
Common Side Effects of Kliovance: What to Expect
Side effects are classified by frequency. Most are mild and temporary. The table below lists side effects reported in clinical trials and from post‑marketing experience.
| Frequency | Side Effects |
|---|---|
| Very common (>1/10) | Breast pain/tenderness, vaginal bleeding (spotting or breakthrough bleeding) |
| Common (1/10–1/100) | Headache, migraine, nausea, depression, weight gain, fluid retention, back pain, leg cramps, vaginal inflammation, fungal infection |
| Uncommon (1/100–1/1,000) | Acne, hair loss, hives, itching, bloating, nervousness, superficial vein inflammation |
| Rare (1/1,000–1/10,000) | Deep vein thrombosis, pulmonary embolism |
| Very rare (<1/10,000) | Endometrial hyperplasia/cancer (when not properly opposed – but progestogen in Kliovance prevents this), hypertension, gallstones, angioedema, heart attack, stroke |
📌 Note: This list is not exhaustive. If you experience any new or worsening symptoms, report them to your doctor or pharmacist.
When Do Kliovance Side Effects Start?
Most side effects appear within the first 1‑3 months of treatment, coinciding with the body's adaptation to steady hormone levels.
- Breast tenderness and nausea: Often start within the first few days to weeks.
- Spotting/breakthrough bleeding: Typically occurs in the first 3‑6 months as the endometrium adjusts to continuous progestogen.
- Headache and mood changes: Can emerge within the first month and usually improve with time.
- Serious side effects (e.g., blood clots): Risk is highest during the first year of use, but can occur at any time.
If side effects appear after you have been stable on Kliovance for many months, inform your doctor – this may indicate a need for dose adjustment or further investigation.
How Long Do Kliovance Side Effects Last?
The duration varies by side effect:
- Breast tenderness, nausea, headache: Usually resolve within 2‑3 months as the body acclimatises. If persistent, a dose reduction may be considered.
- Spotting/breakthrough bleeding: Most women experience irregular bleeding in the first 3‑6 months. After that, bleeding usually stops or becomes very light. If bleeding continues beyond 6 months or starts again later, seek medical evaluation.
- Mood changes and fluid retention: Often improve within the first few months. If they persist or become severe, discuss alternatives with your doctor.
- Serious side effects: If a blood clot or cancer occurs, treatment is stopped and the underlying condition is managed independently.
If you stop Kliovance, most hormone‑related side effects will resolve within a few weeks.
Kliovance Side Effects Timeline: A Week‑by‑Week Guide
Understanding the typical progression can help you distinguish normal adjustment from problems that need attention.
| Timeframe | What to Expect |
|---|---|
| Days 1‑30 | Possible breast tenderness, nausea, mild headache. Spotting may begin, especially if switching from another HRT. |
| Weeks 4‑12 | Breast tenderness and nausea often start to subside. Spotting may continue intermittently. Some women notice improved sleep and reduced hot flushes. |
| Months 3‑6 | Spotting typically becomes less frequent or stops. Most initial side effects resolve. If spotting persists or becomes heavy, inform your doctor. |
| After 6 months | Side effects should be minimal. Persistent or new symptoms should be evaluated. Regular annual check‑ups continue. |
⚕️ Clinical note: This timeline is a general guide. Individual experiences vary. Always discuss any concerns with your healthcare provider.
Contraindications: Who Should Not Take Kliovance
Kliovance is not suitable for everyone. Do not take it if any of the following apply. If you are unsure, consult your doctor.
- Breast cancer, or suspected breast cancer.
- Oestrogen‑sensitive cancer (e.g., endometrial cancer) or suspicion of it.
- Any unexplained vaginal bleeding.
- Untreated endometrial hyperplasia.
- Current or past blood clot in a vein (deep vein thrombosis, pulmonary embolism).
- Known blood clotting disorder (e.g., protein C, protein S deficiency).
- Recent heart attack, stroke, or angina caused by arterial clots.
- Liver disease with abnormal liver function tests.
- Porphyria (inherited blood disorder).
- Allergy to estradiol, norethisterone, or any excipient (including lactose).
- Pregnancy or breastfeeding.
If any of these conditions develop while taking Kliovance, stop immediately and consult your doctor.
Food Interactions with Kliovance: What You Need to Know
Kliovance can be taken with or without food; meals do not significantly affect absorption. However, there are a few considerations:
- Grapefruit juice: Avoid large amounts of grapefruit juice. It may inhibit CYP3A4, potentially increasing oestrogen levels, though clinical significance is low.
- Alcohol: Moderate alcohol consumption is generally safe, but excessive intake may increase the risk of breast cancer with long‑term HRT.
- St John’s Wort (herbal remedy): Not a food, but often taken as a supplement. It reduces hormone levels and may cause breakthrough bleeding and loss of efficacy. Avoid.
- Lactose intolerance: Each tablet contains 71.6 mg lactose. If you have severe lactose intolerance or galactosaemia, Kliovance may not be suitable.
Always inform your doctor or pharmacist about any supplements or herbal products you are taking.
Serious Side Effects & When to Seek Medical Help
While rare, some side effects require immediate medical attention. Stop Kliovance and seek help if you experience:
- Signs of a blood clot: Swelling, pain, or redness in one leg; sudden chest pain; difficulty breathing; coughing up blood.
- Stroke symptoms: Sudden severe headache, facial drooping, weakness on one side, confusion, trouble speaking.
- Heart attack symptoms: Chest pain spreading to arm or jaw, shortness of breath, sweating.
- Jaundice: Yellowing of skin or whites of eyes (liver problem).
- Angioedema: Swollen face, tongue, or throat; difficulty swallowing or breathing.
- Persistent heavy bleeding: Soaking through pads frequently, clots, or bleeding after 6 months of use.
- Breast changes: New lump, dimpling, nipple discharge, or skin changes.
Regular check‑ups (at least annually) and mammograms as recommended by your doctor are essential for early detection of serious conditions.
Kliovance Side Effects FAQs
Will Kliovance side effects go away on their own?
Yes, most side effects like breast tenderness, nausea, and spotting are temporary and settle within 2‑6 months as your body adjusts to the hormones.
How can I reduce Kliovance side effects like breast pain?
Wear a well‑fitting supportive bra, take your tablet after food, and avoid caffeine if sensitive. If pain persists beyond 3 months, speak to your doctor.
Can I take Kliovance with other medications to manage side effects?
Some medicines interact with Kliovance (e.g., rifampicin, anticonvulsants). Always inform your doctor about all medications before starting HRT.
Is it safe to drink alcohol while taking Kliovance?
Moderate alcohol is generally safe, but heavy drinking may increase breast cancer risk with long‑term HRT. Stick to sensible limits (≤14 units/week).
What should I do if I experience severe side effects from Kliovance?
Stop taking Kliovance and seek medical advice immediately if you have signs of blood clot, jaundice, severe headache, or sudden breast changes.
Need Personalised Advice on Kliovance Side Effects?
If you are experiencing side effects or have concerns about starting Kliovance, a UK‑registered doctor can review your symptoms, medical history, and recommend the most suitable HRT for you.
Secure Prescription & Next-Day Delivery
GPhC‑registered pharmacy | Discreet packaging | Ongoing clinical support
Start Menopause ConsultationRelated Kliovance Guides
Medical Content Manager
Nabeel is a co-founder, and medical content manager of Chemist Doctor. He works closely with our medical team to ensure the information is accurate and up-to-date.
Medical Doctor
Dr. Feroz is a GMC-registered doctor and a medical reviewer at Chemist Doctor. He oversees acute condition and urgent care guidance.
Medical Director
Usman is a co-founder, and medical director of Chemist Doctor. He leads the organisation's strategic vision, bridging clinical and operational priorities.
Review Date: 27 March 2026
Next Review: 27 September 2026
Published on: 27 March 2026
Last Updated: 27 March 2026